Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Blood

Volumn 105, Issue 5, 2005, Pages 1851-1861

  Monti, Stefano ^b   Savage, Kerry J ^b   Kutok, Jeffery L ^b   Feuerhake, Friedrich ^b   Kurtin, Paul ^b   Mihm, Martin ^b   Wu, Bingyan ^b   Pasqualucci, Laura ^b   Neuberg, Donna ^b   Aguiar, Ricardo C T ^b   Cin, Paola Dal ^b   Ladd, Christine ^b   Pinkus, Geraldine S ^b   Salles, Gilles ^b   Harris, Nancy Lee ^b   Dalla Favera, Riccardo ^b   Habermann, Thomas M ^b   Aster, Jon C ^b   Golub, Todd R ^b   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; B CELL LYMPHOMA; DENDRITIC CELL; DIFFUSE LARGE B CELL LYMPHOMA; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; CLASSIFICATION; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; LARGE CELL LYMPHOMA; PATHOLOGY; SIGNAL TRANSDUCTION;

CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OXIDATIVE PHOSPHORYLATION; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 20144382754     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2947     Document Type: Article

References (63)

1. Shipp M, Harrington D, Chairpersons, et al. A predictive model for aggressive non-Hodgkin's lymphoma: the International NHL Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
2. Kuppers R, Klein U. Hansmann M-L, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
3. Kramer M, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
4. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412:341-346.
5. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
6. Wright G, Tan B, Rosenwald A, Hurt E, Wiestner A, Staudt L. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA. 2003;100:9991-9996.
7. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68-74.
8. Su T, Quo B, Kawakami Y, et al. PKC-beta controls IkappaB kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol. 2002;3:780-786.
9. Savage K, Monti S, Kutok J, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879.
10. Rosenwald A, Wright G, Leroy K. et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851-862.
11. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
12. Tamayo P, Slonim D, Mesirow J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA. 1999; 96:2907-2912.
13. Cheesman P, Stutz J. Bayesian classification (AutoClass): theory and results. In: Fayyad U, Piatetsky-Shapiro G, Smyth P, Uthurusamy R, eds. Advances in knowledge discovery and data mining. Menlo Park, CA: AAAI Press; 1995.
14. Monti S, Tamayo P, Mesirov J, Golub T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning. 2003; 52:91-118.
15. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34: 267-273.
16. Mihm MJ, Clemente C, Cascinelli N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest. 1996;74:43-47.
17. Arunachalam B, Phan U, Geuze H, Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol rreductase (GILT). Proc Natl Acad Sci USA. 2000;97:745-750.
18. Newmeyer D, Ferguson-Miller S. Mitochondria: releasing power for life and unleasing the machineries of death. Cell. 2003;112:481-490.
19. Werner A, de Vries E, Tait S, Bontjerl, Borst J. BCL-2 family member BFL-1/A1 sequesters truncated bid to inhibit its collaboration with pro-apoptotic BAK or BAX. J Biol Chem. 2002;277: 22781-22788.
20. Almond J, Cohen G. The proteasome: a novel target for cancer chemotherapy. Leukemia. 2002; 16:433-443.
21. Labib K, Tercero J, Diffley J, Uninterrupted MCM2-7 function required for DNA replication fork progression. Science. 2000;288:1643-1647.
22. Kolodner R, Marsischky G. Eukaryotic DNA mismatch repair. Curr Opin Gene Dev. 1999;9:89-96.
23. Bassing C, Sun H, Ferguson D, et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell. 2003;114: 359-370.
24. Manke I, Lowery D, Nguyen A, Yaffe M. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 2003;302: 636-639.
25. Niiro H, Clark E. Regulation of B-cell fate by antigen-receptor signals. Nature Rev. 2002;2:945-956.
26. Bartholdy B, Matthias P. Transcriptional control of B cell development and function. Genes. 2003; 327:1-23.
27. Santana M, Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol. 2003;195:392-401.
28. Gregory C, Devitt A. CD14 and apoptosis. Apoptosis. 1999;4:11-20.
29. Graversen J, Madsen M, Moestrup S. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol. 2002;34:309-314.
30. He Z, Ong C, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med. 2003;9:225-229.
31. Kingsbury G, Feeney L, Nong Y, et al. Cloning, expression, and function of BLAME, a novel member of the CD2 family. J Immunol. 2001;166: 5675-5680.
32. Utans U, Arceci R, Yamashita Y, Russell M. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest. 1995;95:2954-2962.
33. Timms J, Carlberg K, Gu H, et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol. 1998;18: 3838-3850.
34. Maric M, Arunachalam B, Phan U, et al. Defective antigen processing in GILT-free mice. Science. 2001;294:1361-1363.
35. Honey K, Rudensky A. Lysosomal cysteine proteases regulate antigen presentation. Nature Rev. 2003;3:472-482.
36. Aggarwal B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;9:745-756.
37. Chawla-Sarkar M, Lindner D, Liu Y, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis. 2003;3:237-249.
38. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Revlmmunol. 2001;19:623-625.
39. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haemato-poietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
40. Zhang W, Sloan-Lancaster J, Kitchen J, Tnble R, Samelson L. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 1998;92:83-92.
41. Murphy K, Reiner S. The lineage decisions of helper T cells. Nature Rev. 2002;2:933-944.
42. Kim CH, Kunkel EJ, Boisvert J, et al. Bonzo/ CXCR6 expression defines type1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest. 2001;107:595-601.
43. Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505-1516.
44. Bachmann MF, McKall-Faienza K, Schmits R, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity. 1997;7:549-557.
45. Watts C. Antigen presentation - losing its shine in the absence of GILT. Science. 2001;294:1294-1295.
46. Haque M, Li P, Jackson S, et al. Absence of y-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med. 2002; 195:1267-1277.
47. Steht G, Reece J, Baylis D, et al. Heterogeneity of freshly isolated human tonsil dendritic cells demonstrated by intracellular markers, phagocytosis, and membrane dye transfer. Cytometry. 2002;48:167-176.
48. Shortman K, Liu Y-J. Mouse and human dendritic cell subtypes. Nature Rev. 2002;21:151-161.
49. Kikutani H. Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nature Rev. 2003;3:159-167.
50. Andreae S, Piras F, Burdin N, Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol. 2002:3874-3880.
51. Andreae S, Buisson S, Triebel F. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood. 2003;102:2130-2137.
52. Brauninger A, Kuppers R, Spieker T, et al. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood. 1999;93:2679-2687.
53. Lim M, Beaty M, Sorbara L, et al. T-cell/histiocyterich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Amer J Surg Pathol. 2002;26:1458-1466.
54. Aki H, Tuzuner N, Ongoren S, et al. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leukemia Res. 2004;28: 229-236.
55. Bouabdallah R, Mounier N, Guettier C, et al. T-cell/ histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol. 2003;21:1271-1277.
56. Rudiger T, Gascoyne RD, Jaffe ES, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol. 2002;13(suppl 1):44-51.
57. Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma and nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood. 2003;102:3753-3758.
58. Saito T, Chiba S, Ichikawa M, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 2003;18:675-685.
59. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nature Rev. 2003;3:609-620.
60. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol. 2004;172:3268-3279.
61. Mills D, Cambier J. B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologie consequences. Semin Immunol. 2003;6:325-329.
62. Lukacher AE. IFN-gamma suspends the killing license of anti-tumor CTLs. J Clin Invest. 2002; 110:1407-1409.
63. Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, Neuberg DS, Bollag G, Shipp MA, Aguiar RC. The phosphodiesterase PDE4B limits c-AMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood. 2005; 105:308-316.